TAVR and TMVR Explained: How Precision Medical Devices Are Transforming Heart Valve Replacement

For decades, the only option for patients with severe heart valve disease was open-heart surgery: a sternotomy, cardiopulmonary bypass, weeks of recovery, and significant procedural risk. Today, two transcatheter procedures have rewritten that script entirely. Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Replacement (TMVR) allow cardiologists to replace failing heart valves through a small incision, often with the patient going home the next day.

This shift from invasive surgery to minimally invasive intervention represents one of the most important advances in modern cardiovascular medicine. And behind every successful TAVR or TMVR procedure is a sophisticated ecosystem of precision medical devices — guidewires, nitinol-based valve frames, catheter delivery systems, and reinforcement components — that allow clinicians to navigate the heart with extraordinary accuracy.

For Custom Wire Technologies (CWT), supporting this clinical revolution is at the heart of what we do. In this article, we’ll explore how TAVR and TMVR work, why they matter, and the categories of precision wire components that make them possible.

What Is TAVR? Understanding Transcatheter Aortic Valve Replacement

TAVR is a minimally invasive procedure used to treat severe aortic stenosis, a condition in which the aortic valve narrows and stiffens, restricting blood flow from the heart to the rest of the body. Left untreated, severe aortic stenosis leads to heart failure, fainting, chest pain, and significantly shortened life expectancy.

How the TAVR Procedure Works

Rather than opening the chest, interventional cardiologists deliver a new, collapsible bioprosthetic valve to the heart through a catheter. The most common access point is the femoral artery in the groin, though alternative routes through the chest or shoulder are used when peripheral vessels are too small or diseased.

Once the catheter reaches the diseased aortic valve, the new valve is expanded — either by a balloon (balloon-expandable valves) or through self-expansion (self-expanding nitinol-frame valves). The new valve immediately takes over the job of regulating blood flow, pushing the diseased leaflets aside and restoring normal hemodynamics.

Who Is TAVR For?

Originally approved for patients considered too high-risk for open-heart surgery, TAVR has steadily expanded to intermediate- and low-risk patient populations as long-term clinical evidence has accumulated. Today, TAVR is performed in patients across the risk spectrum, with shorter hospital stays, faster recovery, and outcomes that match or exceed traditional surgical aortic valve replacement.

What Is TMVR? Understanding Transcatheter Mitral Valve Replacement

TMVR addresses mitral regurgitation — a condition in which the mitral valve fails to close properly, allowing blood to flow backward into the left atrium with each heartbeat. Severe mitral regurgitation places enormous strain on the heart and lungs, and historically required open-heart surgery to repair or replace the valve.

How the TMVR Procedure Works

Like TAVR, TMVR uses a catheter-based approach. The two most common pathways are:

• Transseptal access: The catheter enters through a vein in the leg, travels up to the heart, and crosses the wall between the right and left atria to reach the mitral valve.
• Transapical access: A small incision in the chest provides direct access to the apex of the left ventricle, offering a more direct path to the mitral valve.

Once positioned, the replacement valve is deployed and anchored within the native mitral annulus. The new valve immediately restores one-way blood flow, eliminating the regurgitation and reducing strain on the heart.

Why TMVR Is More Complex Than TAVR

The mitral valve is anatomically more challenging than the aortic valve. It’s larger, D-shaped rather than circular, surrounded by delicate structures like the chordae tendineae and papillary muscles, and undergoes significant motion throughout the cardiac cycle. It also lacks the calcification that helps anchor a TAVR valve in place. These factors mean TMVR devices must employ sophisticated anchoring systems — often using nitinol arms, atrial flanges, or dedicated docking systems — to stay securely in position.

Who Is TMVR For?

TMVR is currently indicated for patients with severe mitral regurgitation who are at high risk for traditional open-heart surgery. Like TAVR, it offers significantly shorter hospital stays, faster recovery, and reduced procedural trauma compared to surgical mitral valve replacement.

The Clinical Benefits of Transcatheter Valve Replacement

Both TAVR and TMVR have transformed outcomes for patients with valvular heart disease. The key benefits include:

• Minimally invasive access — no sternotomy, no cardiopulmonary bypass
• Shorter hospital stays — many TAVR patients go home within 24–48 hours
• Faster recovery — patients return to daily activities in days rather than weeks
• Lower procedural risk for elderly and high-risk patients
• Expanded treatment eligibility for patients who would not survive open surgery

These benefits are not just a function of surgical technique. They depend on the precision and reliability of the medical devices that make these procedures possible.

The Precision Medical Devices Behind TAVR and TMVR

Every TAVR and TMVR procedure relies on a carefully engineered system of precision components. Each plays a distinct clinical role, and each must meet exacting performance standards. Here are the device categories that form the backbone of structural heart intervention.

1. Structural Heart Guidewires

Guidewires are the “rails” of every transcatheter procedure. They provide the track over which catheters, balloons, and the valve itself are delivered into the heart. In TAVR and TMVR, guidewires must perform two competing jobs at once:

• Provide enough support to track a heavy valve delivery system through the aortic arch or across the interatrial septum
• Remain atraumatic at the tip, where the wire sits inside the delicate left ventricle

Modern structural heart guidewires use pre-shaped distal curves — often a J-loop or pigtail configuration — that distribute force across a broad area of the ventricular wall, reducing the risk of perforation. The proximal sections, by contrast, are engineered for “extra support” to keep the catheter system stable during valve deployment. Producing this gradient of stiffness requires advanced grinding, tapering, and assembly techniques — capabilities CWT brings to its custom guidewire assemblies for OEM partners.

2. Nitinol Valve Frames and Anchoring Systems

Nitinol — a nickel-titanium alloy — is arguably the most important material in the structural heart toolkit. Its two defining properties make it uniquely suited to transcatheter valves:

• Superelasticity: Nitinol can be compressed dramatically to fit inside a small catheter, then spring back to its original shape when deployed in the heart.
• Shape memory: Nitinol components can be set into complex three-dimensional geometries that hold their form under physiological stress.

These properties allow self-expanding TAVR valves to be crimped into delivery sheaths small enough to pass through the femoral artery, then expand to full diameter once positioned in the aortic annulus. In TMVR, nitinol enables the intricate anchoring systems — winglets, atrial flanges, and docking rings — that hold a replacement valve in place against the dynamic motion of the mitral apparatus. The shape-set nitinol coils and frame components used in these devices require specialized processing expertise to deliver consistent radial force and biocompatibility.

3. Catheter Delivery Systems and Reinforcement Coils

The catheter delivery system is what carries the valve from the access point to the heart. These systems must be flexible enough to navigate tortuous vasculature, strong enough to push a bulky valve assembly forward, and stable enough to deploy that valve with millimeter-level precision.

Helical reinforcement coils embedded in the catheter shaft give these devices what engineers call “flexible rigidity” — the ability to bend through tight anatomical curves without kinking, collapsing, or losing the internal lumen. The same coils help transmit the rotational force (torque) clinicians use to orient the valve correctly within the annulus, especially in steerable TMVR systems navigating the sharp turn from the interatrial septum to the mitral valve. (For a deeper look at the engineering behind these components, see our overview of advanced coiling techniques for catheters and guidewires.)

4. Radiopaque Markers and Visualization Components

Because TAVR and TMVR are performed under fluoroscopy, every component in the delivery system must be visible on X-ray imaging. Radiopaque markers — often made from platinum-iridium, platinum-tungsten, or similar dense alloys — are integrated into guidewires, catheters, and valve frames to give clinicians a real-time view of device position. Even small differences in marker placement can affect deployment accuracy, making these components essential to procedural safety.

5. Large-Bore Sheaths and Access Components

The introducer sheath is the gateway to the procedure. For TAVR, sheaths typically range from 14-Fr to 20-Fr in diameter, large enough to accommodate the collapsed valve and its delivery system. These sheaths must resist kinking when bent through the iliac arteries and the aortic arch, and they often feature lubricious coatings to minimize friction during device exchanges. Reinforcement coils integrated into the sheath wall provide the structural backbone that prevents collapse under pressure — the kind of large-bore, fine-tolerance component CWT supports through its medical wire coiling capabilities.

The Future of Structural Heart Intervention

The TAVR and TMVR landscape continues to evolve rapidly, with several major trends shaping the next generation of devices.

Miniaturization

Clinicians and device makers are pushing for smaller delivery systems — moving from 18-Fr toward 14-Fr profiles and beyond. Smaller sheaths reduce vascular complications, expand access to patients with smaller arteries, and shorten recovery times. Achieving this requires components that are simultaneously thinner and stronger.

Expansion to New Patient Populations

As clinical evidence supports TAVR in younger, lower-risk patients, device manufacturers are designing for lifetime valve management — including the possibility of valve-in-valve procedures decades after the initial implant. Durability and re-intervention compatibility are now central design considerations.

Transcatheter Tricuspid Valve Replacement (TTVR)

The next frontier in structural heart intervention is the tricuspid valve, which presents anatomical challenges even greater than the mitral valve. Early TTVR systems are now in clinical evaluation, and they will require many of the same precision engineering principles — large-diameter delivery systems, sophisticated nitinol anchoring, and high-torque steerable catheters — that have powered the TAVR and TMVR revolutions.

Why Precision Medical Device Manufacturing Matters

The clinical success of TAVR and TMVR ultimately rests on the reliability of the components inside every delivery system. A guidewire that kinks at the wrong moment, a nitinol frame that fails to fully expand, or a catheter that loses its lumen mid-procedure can all compromise patient safety. That’s why structural heart device development demands partners with deep expertise in nitinol processing, fine wire engineering, and precision coiling.

At Custom Wire Technologies, we specialize in the categories of components that power TAVR, TMVR, and the broader structural heart device landscape — including custom guidewire assemblies, nitinol coils and shape-set components, catheter reinforcement coils, and value-added services such as laser welding, marker placement, and cleanroom assembly. By partnering with the OEMs developing the next generation of transcatheter valve systems, CWT plays a small but critical role in helping patients live longer, healthier lives.